Research graph
References from Preoperative Proton Pump Inhibitor Use Was Associated With Increased Risk of Revision Surgery and Impaired Bone Healing After Pelvic Fracture Fixation: A Retrospective Cohort Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Gastroesophageal reflux disease
10.1056/nejmcp2114026 · 2022 · External reference
Inhibiting the proton pump: mechanisms, benefits, harms, and questions
10.1186/s12916-016-0724-1 · 2016 · External reference
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders
10.2165/00003495-199856030-00002 · 1998 · External reference
Proton pump inhibitors in GORD an overview of their pharmacology, efficacy and safety
10.1016/j.phrs.2008.09.016 · 2009 · External reference
The physiology of the gastric parietal cell
10.1152/physrev.00016.2019 · 2020 · External reference
Pharmacology of proton pump inhibitors
10.1007/s11894-008-0098-4 · 2008 · External reference
Trends in proton-pump inhibitor use among Danish adults: a nationwide drug utilization study 2015-2023
10.1111/bcpt.70057 · 2025 · External reference
National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017
2020 · External reference
Proton pump inhibitor use: systematic review of global trends and practices
10.1007/s00228-023-03534-z · 2023 · External reference
Side effects of long-term proton pump inhibitor use: a review
10.1111/bcpt.13023 · 2018 · External reference
ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease
10.14309/ajg.0000000000001538 · 2022 · External reference
Proton pump inhibitors: understanding the associated risks and benefits of long-term use
10.1093/ajhp/zxad009 · 2023 · External reference
Proton pump inhibitors, bone and phosphocalcic metabolism
10.1016/j.jbspin.2024.105714 · 2024 · External reference
Proton pump inhibitors and fracture risk: a review of current evidence and mechanisms involved
10.3390/ijerph16091571 · 2019 · External reference
The decisive early phase of bone regeneration
10.1038/s41584-022-00887-0 · 2023 · External reference
Proton pump inhibitors and fractures in adults: a critical appraisal and review of the literature
10.1155/2021/8902367 · 2021 · External reference
Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis
10.1016/j.lfs.2018.12.058 · 2019 · External reference
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study
10.1007/s00198-023-06867-8 · 2023 · External reference
Osteoporotic pelvic fractures
2018 · External reference
Risk factors for pelvic insufficiency fractures and outcome after conservative therapy
10.1016/j.archger.2016.06.020 · 2016 · External reference
Demographic changes in pelvic fracture patterns at a Swiss academic trauma center from 2007 to 2017
10.1097/ta.0000000000003398 · 2022 · External reference
Clinical frailty and short-term outcomes after low-energy pelvic fracture in the geriatric population: nationwide inpatient sample 2016-2018 analysis
10.1016/j.bone.2024.117225 · 2024 · External reference
Operative management of fragility fractures of the pelvis - a systematic review
10.1186/s12891-021-04579-w · 2021 · External reference
Fragility fractures of the pelvic ring: analysis of epidemiology, treatment concepts, and surgical strategies from the registry of the German Pelvic Multicenter Study Group
10.3390/jcm14092935 · 2025 · External reference
Fragility fractures of the pelvis: current practices and future directions
10.1007/s11914-022-00760-9 · 2022 · External reference
Research mapping of trends in conservative management and outcomes of fragility fractures of the pelvis
10.1016/j.injury.2025.112594 · 2025 · External reference
Pelvic trauma: WSES classification and guidelines
10.1186/s13017-017-0117-6 · 2017 · External reference
Proton-pump inhibitors are associated with increased risk of prosthetic joint infection in patients with total hip arthroplasty: a case-cohort study
10.1080/17453674.2021.1920687 · 2021 · External reference
The impact of proton pump inhibitor use on fusion rates following single-level anterior cervical discectomy and fusion
10.1097/bsd.0000000000001749 · 2025 · External reference
The impact of proton pump inhibitors on bone regeneration and implant osseointegration
10.1080/03602532.2019.1610767 · 2019 · External reference
Acid-suppressive medication use and the risk for hospital-acquired pneumonia
10.1001/jama.2009.722 · 2009 · External reference
Use of proton pump inhibitors and risk of ischemic events in the general population
10.1016/j.atherosclerosis.2018.08.035 · 2018 · External reference
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: a cross-sectional study
10.1002/phar.2504 · 2021 · External reference
Association between regular proton pump inhibitors use and cardiovascular outcomes: a large prospective cohort study
10.1016/j.ijcard.2023.131567 · 2024 · External reference
Proton pump inhibitors and bone health: an update narrative review
10.3390/ijms231810733 · 2022 · External reference
Pantoprazole impairs fracture healing in aged mice
10.1038/s41598-020-79605-3 · 2020 · External reference
Proton pump inhibitors inhibit PHOSPHO1 activity and matrix mineralisation in vitro
10.1007/s00223-021-00882-9 · 2021 · External reference
